Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA

被引：47

作者：

Grijalva, Carlos G. ^{[1
]}

Griffin, Marie R. ^{[1
,2
,3
,4
]}

机构：

[1] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA

[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA

[3] VA TN Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN 37212 USA

[4] VA TN Valley Hlth Care Syst, Clin Res Ctr Excellence, Nashville, TN 37212 USA

来源：

EXPERT REVIEW OF VACCINES | 2008年 / 7卷 / 01期

基金：

美国医疗保健研究与质量局;

关键词：

immunization; invasive pneumococcal disease; otitis media; pneumococcal conjugate vaccine; pneumonia; serotypes;

D O I：

10.1586/14760584.7.1.83

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In the year 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for routine immunization of infants in the USA. During the following years, a number of studies documented the impact of this immunization program on rates of invasive pneumococcal disease, pneumonia and otitis media. This article aims to summarize current evidence on the population-based impact of this infant immunization program in the USA.

引用

页码：83 / 95

页数：13

共 79 条

[71] POTENTIAL INTERVENTIONS FOR THE PREVENTION OF CHILDHOOD PNEUMONIA - GEOGRAPHIC AND TEMPORAL DIFFERENCES IN SEROTYPE AND SEROGROUP DISTRIBUTION OF STERILE SITE PNEUMOCOCCAL ISOLATES FROM CHILDREN - IMPLICATIONS FOR VACCINE STRATEGIES [J].

SNIADACK, DH ;

SCHWARTZ, B ;

LIPMAN, H ;

BOGAERTS, J ;

BUTLER, JC ;

DAGAN, R ;

ECHANIZAVILES, G ;

LLOYDEVANS, N ;

FENOLL, A ;

GIRGIS, NI ;

HENRICHSEN, J ;

KLUGMAN, K ;

LEHMANN, D ;

TAKALA, AK ;

VANDEPITTE, J ;

GOVE, S ;

BREIMAN, RF .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (06) :503-510

[72] Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine - A study from a children's hospital emergency department and urgent care center [J].

Stoll, ML ;

Rubin, LG .

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2004, 158 (07) :671-675

[73] Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series [J].

Weisfelt, M ;

van de Beek, D ;

Spanjaard, L ;

Reitsma, JB ;

de Gans, J .

LANCET NEUROLOGY, 2006, 5 (02) :123-129

[74]

WHITE C, 2003, HLTH STAT Q, V20, P25

[75] Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine [J].

Whitney, CG ;

Farley, MM ;

Hadler, J ;

Harrison, LH ;

Bennett, NM ;

Lynfield, R ;

Reingold, A ;

Cieslak, PR ;

Pilishvili, T ;

Jackson, D ;

Facklam, RR ;

Jorgensen, JH ;

Schuchat, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1737-1746

[76] Estimates of world-wide distribution of child deaths from acute respiratory infections [J].

Williams, BG ;

Gouws, E ;

Boschi-Pinto, C ;

Bryce, J ;

Dye, C .

LANCET INFECTIOUS DISEASES, 2002, 2 (01) :25-32

[77] Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine [J].

Wise, RP ;

Iskander, J ;

Pratt, RD ;

Campbell, S ;

Ball, R ;

Pless, RP ;

Braun, MM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1702-1710

[78]

World Health Organization, 2006, DET REV PAP PNEUM CO

[79]

2003, MAMR MORB MORTAL WKL, V54, P893

← 1 2 3 4 5 6 7 8 →